Edition:
United Kingdom

Lexicon Pharmaceuticals Inc (LXRX.OQ)

LXRX.OQ on NASDAQ Stock Exchange Global Select Market

9.01USD
17 Oct 2018
Change (% chg)

$-0.16 (-1.74%)
Prev Close
$9.17
Open
$9.13
Day's High
$9.13
Day's Low
$9.01
Volume
3,925
Avg. Vol
171,247
52-wk High
$13.97
52-wk Low
$7.68

Chart for

About

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of breakthrough treatments for human disease. Its drug programs include XERMELO (telotristat ethyl), sotagliflozin, LX2761 and LX9211. It also has a number of additional compounds into various stages of... (more)

Overall

Beta: 0.15
Market Cap(Mil.): $1,239.53
Shares Outstanding(Mil.): 105.58
Dividend: --
Yield (%): --

Financials

  LXRX.OQ Industry Sector
P/E (TTM): -- 85.92 33.73
EPS (TTM): -1.33 -- --
ROI: -42.10 0.63 14.31
ROE: -85.52 1.68 16.04

BRIEF-Lexicon Pharmaceuticals Reports Q1 Loss Per Share $0.40

* LEXICON PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE

03 May 2018

Competitors

  Price Chg
Pfizer Inc. (PFE.N) $44.11 +0.18
Roche Holding Ltd. (ROG.S) CHF235.30 -5.25
Roche Holding Ltd. (RO.S) CHF236.00 -5.00
Merck & Co., Inc. (MRK.N) $71.07 -0.15
Bayer AG (BAYGn.DE) €77.88 -0.40
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €77.00 +0.59
Eli Lilly And Co (LLY.N) $111.32 +0.29
Abbott Laboratories (ABT.N) $69.98 -0.97
Bristol-Myers Squibb Co (BMY.N) $57.83 0.00

Earnings vs. Estimates